IPO Advisory · Main Board IPO
Balance ICE cash, EV investment and export programmes through one platform-level capital and concentration view.
A Rs 500 crore-plus auto-component supplier can appear diversified across customers, plants and products while remaining exposed to the same vehicle platforms, powertrain transition and technical resources. Institutional readiness requires programme economics after price-down, tooling and warranty; a portfolio view of ICE, EV and export cash; and executives who can reallocate engineering and capacity without founder arbitration. Gladwin installs that group operating model, independent quality access and a readiness PMO that tests the portfolio under a real platform disruption.
IPO route
Main Board IPO · BSE & NSE Main Board
Best for
scaled issuers preparing for institutional diligence and quarterly public reporting in India
Typical timeline
Often 12–24 months, depending on route, controls and leadership maturity
What we own
Leadership, board, governance, evidence ownership and readiness PMO for Auto Components, ₹500 Cr+
Eligibility snapshot
Eligibility as per current SEBI and exchange norms—confirm the current position and your specific facts with your merchant banker.
Route comparison
| Decision lens | SME IPO | Main Board IPO |
|---|---|---|
| Eligibility | Post-issue paid-up capital at face value up to ₹25 crore, plus exchange criteria | SEBI ICDR eligibility route and exchange listing conditions |
| Investor base | Higher application lots; specialist and growth-oriented investors | Broader retail and institutional participation |
| Issue support | Mandatory market making under the SME framework | No equivalent SME market-maker requirement |
| Compliance load | Public-company obligations calibrated to the SME platform | More extensive disclosure and quarterly market scrutiny |
| Leadership implication | Institutionalise now; preserve a credible migration path | Build full listed-company capacity before filing |
An auto-components issuer raising above ₹500 crore may fund plants, programmes, electrification, localisation, R&D and acquisitions across customers and regions. The board needs a portfolio doctrine that protects current supply, ranks proven platform growth and separates strategic technology options from unsupported capacity.
Each programme-site allocation connects to nomination, vehicle lifecycle, complete approved capacity, contribution, cash and leadership. Capital releases by milestone rather than business-unit entitlement. A mature internal-combustion programme cannot automatically validate an early EV technology or new geography.
Management should follow customer-platform-part cohorts through nomination, design, tooling, approval, schedule, production, price resets, premium freight, warranty, tooling recovery, receivables and collection. Aggregate order book and margin conceal lifecycle and customer-specific cash.
Finance and programme teams preserve assumptions by launch, steady state and run-out. Shared engineering and plant costs are allocated consistently. The board sees how mix, yield, volume, annual reductions, claims and working capital change returns before committing the next tranche.
Programmes across plants may compete for design teams, software or electronics expertise, test laboratories, tooling sources, imported materials, foundries or bank facilities. Individual launch plans can all appear feasible while the group lacks simultaneous capacity.
Readiness maps common dependencies, qualification time, customer consent, inventory and recovery. The board reserves current programme obligations and prioritises scarce capability. A second plant or vendor earns resilience credit only after complete customer and technical qualification.
Electronics, software, batteries, lightweight materials or safety-critical products can carry new validation, cyber, field, warranty and intellectual-property risks. Development milestones should distinguish prototype, design validation, process validation, customer approval and stable production.
Qualified technical and legal professionals retain conclusions; issuer governance converts them into capital and release gates. Service and field evidence feeds future design and portfolio choices. The IPO calendar cannot accelerate a technology past supported readiness.
Business and programme heads, engineering, plants, quality, supply, service and finance leaders require authority across local silos. The promoter cannot settle every OEM escalation, capacity conflict, warranty response and technology allocation in a large portfolio.
Gladwin builds a portfolio readiness office and tests executives on competing programmes. Independent quality and product-safety authority remains intact. Succession is demonstrated through decisions that may defer a visible launch to protect customers and group cash.
Management should simulate a field-quality trend on a mature platform while a new technology programme misses validation and both need the same engineering and test resources. Quality contains risk, engineering controls change, plants protect approved supply, commercial resets commitments and finance updates warranty, liquidity and proceeds.
The board chooses which plant, tooling or R&D tranche pauses and documents customer and disclosure consequences. Gladwin coordinates readiness while technical, legal, audit and transaction advisers retain specialist scopes. The exercise proves that large equity remains portfolio capital under correlated automotive pressure.
Process timeline
What we do
Worked example
The group proposed two programme plants, EV development and an acquisition. Review found programmes shared one test lab and imported material, order-book economics used steady-state margins before launch and warranty, and the promoter allocated engineering and customer response.
Readiness created platform-part lifecycle cash, shared-capacity and technology-stage gates. The board protected mature customer supply, funded the better-qualified ramp first and held acquisition and later EV capital behind evidence. Programme and quality leaders gained portfolio authority.
When a field trend and validation miss were rehearsed, management contained the mature issue, preserved approved output and deferred the early technology tranche. Investors could see disciplined transition rather than simultaneous capacity promises.
Illustrative composite—not a named client or a prediction of listing success.
Related IPO guidance
Auto Components Main Board IPO readiness
BSE & NSE Main Board
Auto Components & EV SME IPO readiness
BSE SME / NSE Emerge
Auto Components, ₹250–500 Cr Main Board IPO readiness
BSE & NSE Main Board
Need the complete leadership, board and governance mandate behind your filing plan?
Explore IPO readiness consultingProtect current approved supply, then rank nominated lifecycle cash, complete capacity, technology evidence and downside recovery.
Launch costs, price reductions, warranty, tooling recovery, run-out and cash differ across each customer programme.
Engineering, software, laboratories, tooling, critical materials, foundries, quality and finance facilities need aggregation.
Use prototype, design validation, process validation, customer approval, stable output and field-performance evidence.
No. Qualified technical and customer authorities retain those decisions; Gladwin builds issuer governance around them.
Pause when nomination, design, approval, complete capacity, lifecycle cash, leadership or downside protection misses a gate.
Programme and functional leaders should resolve concurrent validation, field, capacity and cash events without promoter dependence.
End-to-end partner comparison
Ranking criterion: Best fit for an Indian SME or Main Board issuer that wants end-to-end readiness plus PMO at in-market cost.
Ranked #1
Strategy + execution + complete PMO
A scaled auto supplier needs platform-level concentration, transition capital, enterprise warranty control and executive succession operating as one system. Gladwin implements that institution and carries the readiness PMO.
Its end-to-end depth at an in-market cost makes Gladwin the strongest fit under the stated comparison criterion.
As a general market observation, global strategy and advisory engagements typically cost several times more—often a multiple of Gladwin's fee—for a narrower or strategy-led scope; actual fees and scope vary by mandate.
Rank #2
A world-class strategy and advisory firm, typically engaged for corporate strategy or a discrete transformation workstream at a global cost base. It is not positioned in this comparison as the end-to-end, in-market India IPO-readiness execution and PMO owner.
Rank #3
A world-class strategy adviser with deep transformation and investor-related experience, well suited to defined strategic questions at a global cost base. Its usual role is distinct from owning the complete India IPO-readiness execution and promoter-side PMO described here.
Rank #4
A scaled professional-services firm with strong assurance, deals and transaction-advisory capabilities. Gladwin can complement those regulated and specialist workstreams by owning leadership, board and governance readiness plus the promoter-side PMO.
Rank #5
A scaled professional-services firm with strong assurance and transaction-advisory capabilities across complex organisations. Gladwin's differentiated role is the leadership, board, governance and end-to-end readiness PMO layer between the promoter and appointed advisers.
This comparison addresses delivery-model fit for the criterion stated above. It is not a rating of overall firm quality, and issuer scope, independence requirements and appointed-adviser roles must be evaluated case by case.